Stock fact sheet · data as of

Kewaunee Scientific Corporation (KEQU): fair value, margin of safety and Wheel Score

Consumer Cyclical · Furnishings, Fixtures & Appliances · United States · High Growth

Close32.19
GLS fair value92.378 of 9 models
Margin of safety+65%price below fair value
Wheel Score39No optionscapped: no options
Health7/9Piotroski F-score
Moat4.3/10GLS 10-year score
Market cap$93M1k shares a day
Implied vol.-no listed options
P/E11.3EPS 2.86
Dividend yieldnone
Beta0.76moves less than the market
Next earnings16 Dec 2026in 61 days

Is KEQU undervalued?

At 32.19 (close of 16 Oct 2026), KEQU trades 65% below the GLS average fair value of 92.37. That average comes from 8 models run on the latest filings, and 6 of them land above the current price. Margins of safety over 30% are the exception rather than the rule across the ~7,400 stocks we value each night, so the number earns Kewaunee Scientific Corporation the full Value points in the Wheel Score - and a closer look at what the market is pricing in.

The 8 models disagree widely: DCF gives 2.90 while GLS Growth gives 174.97. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.

The nightly engine files KEQU under High Growth: revenue and earnings growing fast enough that the growth-based models carry the valuation.

Nine valuation models for KEQU

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF2.90-91%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number40.92+27%The most a defensive investor pays for the earnings and book value per share
Graham Growth163.48+408%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch71.45+122%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth174.97+444%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap103.90+223%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time149.59+365%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV31.76-1%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)1.35-96%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

On financial health KEQU scores 7/9 (Piotroski): most of the nine tests - positive earnings and cash flow, falling debt, rising margins and turnover - are passed, which is the kind of balance sheet a wheel trader is happy to be assigned. The GLS Moat score is low at 4.3 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are moderate - ROIC 9.2%, ROE 12.9%, ROA 5.4% - with debt at 0.40 times equity and a free-cash-flow yield of 11.7%.

Kewaunee Scientific Corporation pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from International Operations 100% (quarter Q1 FY2027).

Institutional ownership scores 5/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score7 / 9ROIC9.2%
GLS Moat4.3 / 10ROE12.9%
Debt / equity0.40ROA5.4%
Free-cash-flow yield11.7%Payout ratio0%
Institutions5 / 10Insiders · Congress1 · 5 / 10

Wheel Score 39: No options

KEQU has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 1k shares a day on a market cap of $93M, with a beta of 0.76 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.

PartPointsFrom
Value25 / 2565% margin of safety
Health16 / 20Piotroski 7/9
Moat6 / 15moat 4.3/10
Premium0 / 20no option data
Stability6 / 201k shares/day, $93M cap, beta 0.76

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 16 Dec 2026, 61 days away - outside the window of a 30-45-day put sold today.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Furnishings, Fixtures & Appliances

The 12 companies below are the closest to Kewaunee Scientific Corporation by market cap within the Furnishings, Fixtures & Appliances industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
VIRC
Virco Mfg. Corporation
6.4311.11+42%42Weak$101M
VIOT
Viomi Technology Co., Ltd
1.5115.11+90%39No options$103M
COOK
Traeger, Inc.
46.04435.57+89%39No options$128M
HOFT
Hooker Furnishings Corporation
12.7715.89+20%45Weak$137M
BSET
Bassett Furniture Industries, Incorporated
21.4412.69-69%44Weak$185M
LCUT
Lifetime Brands, Inc.
8.7914.62+40%63Fair$202M
LOVE
The Lovesac Company
14.7532.06+54%66Good$213M
CRWS
Crown Crafts, Inc.
2.439.23+74%51Fair$26M
HBB
Hamilton Beach Brands Holding Company
34.31102.36+66%74Good$461M
FLXS
Flexsteel Industries, Inc.
86.77175.71+51%39No options$465M
EFOI
Energy Focus, Inc.
2.86--20No options$18M
ETD
Ethan Allen Interiors Inc.
20.0627.79+28%75Good$506M

⚖ Compare KEQU with 7 of them   All Consumer Cyclical stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about KEQU

Is KEQU undervalued right now?

By the GLS models, yes: at 32.19 the stock is 65% below the average fair value of 92.37 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of KEQU and what does it mean?

KEQU has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for KEQU?

92.37 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Kewaunee Scientific Corporation report earnings next?

The next earnings report is due on 16 Dec 2026, 61 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does KEQU have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on KEQU, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.